The writer ties together Nebraska compounding data, a pediatric obesity review and a report on online retatrutide that tested at half to double the labeled dose.
Recap by typeshit. Post by X on X.
He says close to 40% of weight lost in the trial's body-scan group was lean mass, and argues muscle loss isn't the drug's fault.
Wayne Pratt walks through what happens in the brain when drugs like Ozempic dial down the constant background chatter about eating.
Bikman cites a trial where people who lost about 21% and switched to placebo regained 14% within a year, while those who stayed on kept losing.
In Genome Medicine, diet-triggered delivery beat constant secretion on fat and liver fat, and kept down gut microbes carrying GLP-1-degrading peptidase genes.
A hashtag page of personal Trulicity posts, including one user who says insurance denied Ozempic because she was only prediabetic.
The Times reports plans that could put Wegovy on Ireland's public health service, a potential shift in who can get the drug without paying privately.
Loading…